Global and China Dermatomycoses Drug Market Insights, Forecast to 2026

Global and China Dermatomycoses Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Dermatomycoses Drug Product Introduction
1.2 Market Segments
1.3 Key Dermatomycoses Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dermatomycoses Drug Market Size Growth Rate by Type
1.4.2 BB-2603
1.4.3 Clotrimazole
1.4.4 Dapaconazole
1.4.5 Others
1.5 Market by Application
1.5.1 Global Dermatomycoses Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dermatomycoses Drug Market Size, Estimates and Forecasts
2.1.1 Global Dermatomycoses Drug Revenue 2015-2026
2.1.2 Global Dermatomycoses Drug Sales 2015-2026
2.2 Global Dermatomycoses Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Dermatomycoses Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Dermatomycoses Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Dermatomycoses Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Dermatomycoses Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Dermatomycoses Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Dermatomycoses Drug Revenue Forecast by Region (2021-2026)
3 Global Dermatomycoses Drug Competitor Landscape by Players
3.1 Global Top Dermatomycoses Drug Sales by Manufacturers
3.1.1 Global Dermatomycoses Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Dermatomycoses Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Dermatomycoses Drug Manufacturers by Revenue
3.2.1 Global Dermatomycoses Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Dermatomycoses Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dermatomycoses Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dermatomycoses Drug Revenue in 2019
3.2.5 Global Dermatomycoses Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Dermatomycoses Drug Price by Manufacturers
3.4 Global Dermatomycoses Drug Manufacturing Base Distribution, Product Types
3.4.1 Dermatomycoses Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dermatomycoses Drug Product Type
3.4.3 Date of International Manufacturers Enter into Dermatomycoses Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dermatomycoses Drug Market Size by Type (2015-2020)
4.1.1 Global Dermatomycoses Drug Sales by Type (2015-2020)
4.1.2 Global Dermatomycoses Drug Revenue by Type (2015-2020)
4.1.3 Dermatomycoses Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dermatomycoses Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Dermatomycoses Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Dermatomycoses Drug Revenue Forecast by Type (2021-2026)
4.2.3 Dermatomycoses Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dermatomycoses Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Dermatomycoses Drug Market Size by Application (2015-2020)
5.1.1 Global Dermatomycoses Drug Sales by Application (2015-2020)
5.1.2 Global Dermatomycoses Drug Revenue by Application (2015-2020)
5.1.3 Dermatomycoses Drug Price by Application (2015-2020)
5.2 Dermatomycoses Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Dermatomycoses Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Dermatomycoses Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Dermatomycoses Drug Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Dermatomycoses Drug Market Size YoY Growth 2015-2026
6.1.1 China Dermatomycoses Drug Sales YoY Growth 2015-2026
6.1.2 China Dermatomycoses Drug Revenue YoY Growth 2015-2026
6.1.3 China Dermatomycoses Drug Market Share in Global Market 2015-2026
6.2 China Dermatomycoses Drug Market Size by Players (International and Local Players)
6.2.1 China Top Dermatomycoses Drug Players by Sales (2015-2020)
6.2.2 China Top Dermatomycoses Drug Players by Revenue (2015-2020)
6.3 China Dermatomycoses Drug Historic Market Review by Type (2015-2020)
6.3.1 China Dermatomycoses Drug Sales Market Share by Type (2015-2020)
6.3.2 China Dermatomycoses Drug Revenue Market Share by Type (2015-2020)
6.3.3 China Dermatomycoses Drug Price by Type (2015-2020)
6.4 China Dermatomycoses Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Dermatomycoses Drug Sales Forecast by Type (2021-2026)
6.4.2 China Dermatomycoses Drug Revenue Forecast by Type (2021-2026)
6.4.3 China Dermatomycoses Drug Price Forecast by Type (2021-2026)
6.5 China Dermatomycoses Drug Historic Market Review by Application (2015-2020)
6.5.1 China Dermatomycoses Drug Sales Market Share by Application (2015-2020)
6.5.2 China Dermatomycoses Drug Revenue Market Share by Application (2015-2020)
6.5.3 China Dermatomycoses Drug Price by Application (2015-2020)
6.6 China Dermatomycoses Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Dermatomycoses Drug Sales Forecast by Application (2021-2026)
6.6.2 China Dermatomycoses Drug Revenue Forecast by Application (2021-2026)
6.6.3 China Dermatomycoses Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Dermatomycoses Drug Market Size YoY Growth 2015-2026
7.2 North America Dermatomycoses Drug Market Facts & Figures by Country
7.2.1 North America Dermatomycoses Drug Sales by Country (2015-2020)
7.2.2 North America Dermatomycoses Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Dermatomycoses Drug Market Size YoY Growth 2015-2026
8.2 Europe Dermatomycoses Drug Market Facts & Figures by Country
8.2.1 Europe Dermatomycoses Drug Sales by Country
8.2.2 Europe Dermatomycoses Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Dermatomycoses Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Dermatomycoses Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Dermatomycoses Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Dermatomycoses Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Dermatomycoses Drug Market Size YoY Growth 2015-2026
10.2 Latin America Dermatomycoses Drug Market Facts & Figures by Country
10.2.1 Latin America Dermatomycoses Drug Sales by Country
10.2.2 Latin America Dermatomycoses Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Dermatomycoses Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Dermatomycoses Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Dermatomycoses Drug Sales by Country
11.2.2 Middle East and Africa Dermatomycoses Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Anacor Pharmaceuticals Inc
12.1.1 Anacor Pharmaceuticals Inc Corporation Information
12.1.2 Anacor Pharmaceuticals Inc Description and Business Overview
12.1.3 Anacor Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Anacor Pharmaceuticals Inc Dermatomycoses Drug Products Offered
12.1.5 Anacor Pharmaceuticals Inc Recent Development
12.2 Biolab Farmaceutica Ltda
12.2.1 Biolab Farmaceutica Ltda Corporation Information
12.2.2 Biolab Farmaceutica Ltda Description and Business Overview
12.2.3 Biolab Farmaceutica Ltda Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Biolab Farmaceutica Ltda Dermatomycoses Drug Products Offered
12.2.5 Biolab Farmaceutica Ltda Recent Development
12.3 Blueberry Therapeutics Ltd
12.3.1 Blueberry Therapeutics Ltd Corporation Information
12.3.2 Blueberry Therapeutics Ltd Description and Business Overview
12.3.3 Blueberry Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Blueberry Therapeutics Ltd Dermatomycoses Drug Products Offered
12.3.5 Blueberry Therapeutics Ltd Recent Development
12.4 Daewoong Pharmaceutical Co Ltd
12.4.1 Daewoong Pharmaceutical Co Ltd Corporation Information
12.4.2 Daewoong Pharmaceutical Co Ltd Description and Business Overview
12.4.3 Daewoong Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Products Offered
12.4.5 Daewoong Pharmaceutical Co Ltd Recent Development
12.5 Dermala Inc
12.5.1 Dermala Inc Corporation Information
12.5.2 Dermala Inc Description and Business Overview
12.5.3 Dermala Inc Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Dermala Inc Dermatomycoses Drug Products Offered
12.5.5 Dermala Inc Recent Development
12.6 Helix BioMedix Inc
12.6.1 Helix BioMedix Inc Corporation Information
12.6.2 Helix BioMedix Inc Description and Business Overview
12.6.3 Helix BioMedix Inc Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Helix BioMedix Inc Dermatomycoses Drug Products Offered
12.6.5 Helix BioMedix Inc Recent Development
12.7 Novan Inc
12.7.1 Novan Inc Corporation Information
12.7.2 Novan Inc Description and Business Overview
12.7.3 Novan Inc Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novan Inc Dermatomycoses Drug Products Offered
12.7.5 Novan Inc Recent Development
12.8 Sol-Gel Technologies Ltd
12.8.1 Sol-Gel Technologies Ltd Corporation Information
12.8.2 Sol-Gel Technologies Ltd Description and Business Overview
12.8.3 Sol-Gel Technologies Ltd Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sol-Gel Technologies Ltd Dermatomycoses Drug Products Offered
12.8.5 Sol-Gel Technologies Ltd Recent Development
12.9 TGV-Laboratories
12.9.1 TGV-Laboratories Corporation Information
12.9.2 TGV-Laboratories Description and Business Overview
12.9.3 TGV-Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.9.4 TGV-Laboratories Dermatomycoses Drug Products Offered
12.9.5 TGV-Laboratories Recent Development
12.10 Viamet Pharmaceuticals Inc
12.10.1 Viamet Pharmaceuticals Inc Corporation Information
12.10.2 Viamet Pharmaceuticals Inc Description and Business Overview
12.10.3 Viamet Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Viamet Pharmaceuticals Inc Dermatomycoses Drug Products Offered
12.10.5 Viamet Pharmaceuticals Inc Recent Development
12.11 Anacor Pharmaceuticals Inc
12.11.1 Anacor Pharmaceuticals Inc Corporation Information
12.11.2 Anacor Pharmaceuticals Inc Description and Business Overview
12.11.3 Anacor Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Anacor Pharmaceuticals Inc Dermatomycoses Drug Products Offered
12.11.5 Anacor Pharmaceuticals Inc Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Dermatomycoses Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dermatomycoses Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Dermatomycoses Drug Market Segments
Table 2. Ranking of Global Top Dermatomycoses Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dermatomycoses Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of BB-2603
Table 5. Major Manufacturers of Clotrimazole
Table 6. Major Manufacturers of Dapaconazole
Table 7. Major Manufacturers of Others
Table 8. Global Dermatomycoses Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Dermatomycoses Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Dermatomycoses Drug Sales by Regions 2015-2020 (K Units)
Table 11. Global Dermatomycoses Drug Sales Market Share by Regions (2015-2020)
Table 12. Global Dermatomycoses Drug Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Dermatomycoses Drug Sales Forecast by Region (2021-2026) (K Units)
Table 14. Global Dermatomycoses Drug Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Dermatomycoses Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Dermatomycoses Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Dermatomycoses Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatomycoses Drug as of 2019)
Table 18. Dermatomycoses Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Dermatomycoses Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Dermatomycoses Drug Price (2015-2020) (USD/Unit)
Table 21. Dermatomycoses Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Dermatomycoses Drug Product Type
Table 23. Date of International Manufacturers Enter into Dermatomycoses Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Dermatomycoses Drug Sales by Type (2015-2020) (K Units)
Table 26. Global Dermatomycoses Drug Sales Share by Type (2015-2020)
Table 27. Global Dermatomycoses Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Dermatomycoses Drug Revenue Share by Type (2015-2020)
Table 29. Dermatomycoses Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Dermatomycoses Drug Sales Share by Type (2021-2026)
Table 31. Global Dermatomycoses Drug Sales by Application (2015-2020) (K Units)
Table 32. Global Dermatomycoses Drug Sales Share by Application (2015-2020)
Table 33. Global Dermatomycoses Drug Sales Share by Application (2021-2026)
Table 34. Global Dermatomycoses Drug Sales Market Share Forecast by Application (2021-2026)
Table 35. Global Dermatomycoses Drug Revenue by Application (2015-2020) (US$ Million)
Table 36. Global Dermatomycoses Drug Revenue Market Share Forecast by Application (2021-2026)
Table 37. China Dermatomycoses Drug Sales (K Units) of Key Companies (2015-2020)
Table 38. China Dermatomycoses Drug Sales Share by Company (2015-2020)
Table 39. China Dermatomycoses Drug Revenue (US$ Million) by Company (2015-2020)
Table 40. China Dermatomycoses Drug Sales (K Units) by Type (2015-2020)
Table 41. China Dermatomycoses Drug Sales Share by Type (2015-2020)
Table 42. China Dermatomycoses Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. China Dermatomycoses Drug Price (K Units) by Type (2015-2020)
Table 44. China Dermatomycoses Drug Sales (K Units) by Type (2021-2026)
Table 45. China Dermatomycoses Drug Sales Share by Type (2021-2026)
Table 46. China Dermatomycoses Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. China Dermatomycoses Drug Revenue Share by Type (2021-2026)
Table 48. China Dermatomycoses Drug Price (K Units) by Type (2021-2026)
Table 49. China Dermatomycoses Drug Sales (K Units) by Application (2015-2020)
Table 50. China Dermatomycoses Drug Sales Share by Application (2015-2020)
Table 51. China Dermatomycoses Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. China Dermatomycoses Drug Sales (K Units) by Application (2021-2026)
Table 53. China Dermatomycoses Drug Sales Share by Application (2021-2026)
Table 54. China Dermatomycoses Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. China Dermatomycoses Drug Revenue Share by Application (2021-2026)
Table 56. North America Dermatomycoses Drug Sales by Country (2015-2020) (K Units)
Table 57. North America Dermatomycoses Drug Sales Market Share by Country (2015-2020)
Table 58. North America Dermatomycoses Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. North America Dermatomycoses Drug Revenue Market Share by Country (2015-2020)
Table 60. Europe Dermatomycoses Drug Sales by Country (2015-2020) (K Units)
Table 61. Europe Dermatomycoses Drug Sales Market Share by Country (2015-2020)
Table 62. Europe Dermatomycoses Drug Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe Dermatomycoses Drug Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific Dermatomycoses Drug Sales by Region (2015-2020) (K Units)
Table 65. Asia Pacific Dermatomycoses Drug Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific Dermatomycoses Drug Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific Dermatomycoses Drug Revenue Market Share by Region (2015-2020)
Table 68. Latin America Dermatomycoses Drug Sales by Country (2015-2020) (K Units)
Table 69. Latin America Dermatomycoses Drug Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa Dermatomycoses Drug Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America Dermatomycoses Drug Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Dermatomycoses Drug Sales by Country (2015-2020) (K Units)
Table 73. Middle East and Africa Dermatomycoses Drug Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Dermatomycoses Drug Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Dermatomycoses Drug Revenue Market Share by Country (2015-2020)
Table 76. Anacor Pharmaceuticals Inc Corporation Information
Table 77. Anacor Pharmaceuticals Inc Description and Business Overview
Table 78. Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Anacor Pharmaceuticals Inc Dermatomycoses Drug Product
Table 80. Anacor Pharmaceuticals Inc Recent Development
Table 81. Biolab Farmaceutica Ltda Corporation Information
Table 82. Biolab Farmaceutica Ltda Description and Business Overview
Table 83. Biolab Farmaceutica Ltda Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Biolab Farmaceutica Ltda Product
Table 85. Biolab Farmaceutica Ltda Recent Development
Table 86. Blueberry Therapeutics Ltd Corporation Information
Table 87. Blueberry Therapeutics Ltd Description and Business Overview
Table 88. Blueberry Therapeutics Ltd Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Blueberry Therapeutics Ltd Product
Table 90. Blueberry Therapeutics Ltd Recent Development
Table 91. Daewoong Pharmaceutical Co Ltd Corporation Information
Table 92. Daewoong Pharmaceutical Co Ltd Description and Business Overview
Table 93. Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Daewoong Pharmaceutical Co Ltd Product
Table 95. Daewoong Pharmaceutical Co Ltd Recent Development
Table 96. Dermala Inc Corporation Information
Table 97. Dermala Inc Description and Business Overview
Table 98. Dermala Inc Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Dermala Inc Product
Table 100. Dermala Inc Recent Development
Table 101. Helix BioMedix Inc Corporation Information
Table 102. Helix BioMedix Inc Description and Business Overview
Table 103. Helix BioMedix Inc Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Helix BioMedix Inc Product
Table 105. Helix BioMedix Inc Recent Development
Table 106. Novan Inc Corporation Information
Table 107. Novan Inc Description and Business Overview
Table 108. Novan Inc Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Novan Inc Product
Table 110. Novan Inc Recent Development
Table 111. Sol-Gel Technologies Ltd Corporation Information
Table 112. Sol-Gel Technologies Ltd Description and Business Overview
Table 113. Sol-Gel Technologies Ltd Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Sol-Gel Technologies Ltd Product
Table 115. Sol-Gel Technologies Ltd Recent Development
Table 116. TGV-Laboratories Corporation Information
Table 117. TGV-Laboratories Description and Business Overview
Table 118. TGV-Laboratories Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. TGV-Laboratories Product
Table 120. TGV-Laboratories Recent Development
Table 121. Viamet Pharmaceuticals Inc Corporation Information
Table 122. Viamet Pharmaceuticals Inc Description and Business Overview
Table 123. Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Viamet Pharmaceuticals Inc Product
Table 125. Viamet Pharmaceuticals Inc Recent Development
Table 126. Vyome Biosciences Pvt Ltd Corporation Information
Table 127. Vyome Biosciences Pvt Ltd Description and Business Overview
Table 128. Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Vyome Biosciences Pvt Ltd Product
Table 130. Vyome Biosciences Pvt Ltd Recent Development
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key Dermatomycoses Drug Players
Table 135. Dermatomycoses Drug Customers List
Table 136. Dermatomycoses Drug Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermatomycoses Drug Product Picture
Figure 2. Global Dermatomycoses Drug Sales Market Share by Type in 2020 & 2026
Figure 3. BB-2603 Product Picture
Figure 4. Clotrimazole Product Picture
Figure 5. Dapaconazole Product Picture
Figure 6. Others Product Picture
Figure 7. Global Dermatomycoses Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Dermatomycoses Drug Report Years Considered
Figure 12. Global Dermatomycoses Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Dermatomycoses Drug Sales 2015-2026 (K Units)
Figure 14. Global Dermatomycoses Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Dermatomycoses Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Dermatomycoses Drug Sales Market Share by Region in 2019
Figure 17. Global Dermatomycoses Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Dermatomycoses Drug Revenue Market Share by Region in 2019
Figure 19. Global Dermatomycoses Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Dermatomycoses Drug Revenue in 2019
Figure 21. Dermatomycoses Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Dermatomycoses Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Dermatomycoses Drug Sales Market Share by Type in 2019
Figure 24. Global Dermatomycoses Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Dermatomycoses Drug Revenue Market Share by Type in 2019
Figure 26. Global Dermatomycoses Drug Market Share by Price Range (2015-2020)
Figure 27. Global Dermatomycoses Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Dermatomycoses Drug Sales Market Share by Application in 2019
Figure 29. Global Dermatomycoses Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Dermatomycoses Drug Revenue Market Share by Application in 2019
Figure 31. China Dermatomycoses Drug Sales Growth Rate 2015-2026 (K Units)
Figure 32. China Dermatomycoses Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. China Dermatomycoses Drug Market Share in Global Market 2015-2026
Figure 34. China 5 and 10 Largest Dermatomycoses Drug Players Market Share by Revenue in Dermatomycoses Drug in 2019
Figure 35. China Dermatomycoses Drug Revenue Share by Type (2015-2020)
Figure 36. China Dermatomycoses Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 37. China Dermatomycoses Drug Revenue Share by Application (2015-2020)
Figure 38. China Dermatomycoses Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 39. North America Dermatomycoses Drug Sales Growth Rate 2015-2020 (K Units)
Figure 40. North America Dermatomycoses Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Dermatomycoses Drug Sales Market Share by Country in 2019
Figure 42. North America Dermatomycoses Drug Revenue Market Share by Country in 2019
Figure 43. U.S. Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 44. U.S. Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 46. Canada Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Europe Dermatomycoses Drug Sales Growth Rate 2015-2020 (K Units)
Figure 48. Europe Dermatomycoses Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe Dermatomycoses Drug Sales Market Share by Country in 2019
Figure 50. Europe Dermatomycoses Drug Revenue Market Share by Country in 2019
Figure 51. Germany Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 52. Germany Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 54. France Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. U.K. Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 56. U.K. Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Italy Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 58. Italy Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Russia Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 60. Russia Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Asia Pacific Dermatomycoses Drug Sales Growth Rate 2015-2020 (K Units)
Figure 62. Asia Pacific Dermatomycoses Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Dermatomycoses Drug Sales Market Share by Region in 2019
Figure 64. Asia Pacific Dermatomycoses Drug Revenue Market Share by Region in 2019
Figure 65. China Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 66. China Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 68. Japan Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 70. South Korea Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 72. India Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 74. Australia Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 76. Taiwan Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 78. Indonesia Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 80. Thailand Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 82. Malaysia Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 84. Philippines Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 86. Vietnam Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Latin America Dermatomycoses Drug Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Dermatomycoses Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Dermatomycoses Drug Sales Market Share by Country in 2019
Figure 90. Latin America Dermatomycoses Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Middle East and Africa Dermatomycoses Drug Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Dermatomycoses Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Dermatomycoses Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Dermatomycoses Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Dermatomycoses Drug Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Dermatomycoses Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Porter's Five Forces Analysis
Figure 108. Dermatomycoses Drug Value Chain
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs